PAREXEL Renames Perceptive Informatics Subsidiary
PAREXEL announced a group of initiatives that include a re-designed corporate website
PAREXEL announced a group of initiatives that include a re-designed corporate website, a global marketing and advertising campaign and the rebranding of its technology subsidiary Perceptive Informatics to PAREXEL informatics.
According to the company's press release, the PAREXEL Informatics branding is in response to sponsors seeking multiple solutions from a single service provider. Said Mark A. Goldberg, President and Chief Operating Officer, PAREXEL in that release, "We are more closely integrating our clinical research and technology offerings to meet this need. Toward that end, the new PAREXEL Informatics branding communicates our commitment to providing technology-driven solutions that complement our other clinical trial services, without changing our overall go-to-market strategy."
PAREXEL will maintain the Perceptive brands to identify specific PAREXEL Informatics offerings that have market recognition that has been built over the years. These include Perceptive MyTrials eClinical platform, the Perceptive Partner Program and the Perceptive Institute.
Read the full release
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Related Articles
- Everything to Know About FDA’s Push Towards Radical Transparency in 2025
September 17th 2025
- IQVIA and Veeva Join Forces to Improve Efficiency and Patient Outcomes
September 17th 2025
- Managing Background Therapies in the NIMBLE Phase III Trial
September 17th 2025
- Generative AI Transforms Clinical Study Report Development
September 16th 2025